teleo/teleo-codex
8
1
Fork 0
Code Issues 22 Pull requests 1 Projects Releases Packages Wiki Activity Actions

reweave: connect 16 orphan claims #2640

Closed
m3taversal wants to merge 0 commits from reweave/2026-04-12 into main
pull from: reweave/2026-04-12
merge into: teleo:main
Conversation 4 Commits - Files changed -
m3taversal commented 2026-04-12 01:09:46 +00:00
Owner
Copy link

Orphan Reweave

Connected 16 orphan claims to the knowledge graph via vector similarity (threshold 0.7) + Haiku edge classification.

Edges Added

  • Mechanistic interpretability through emotion vecto → [supports] → Emotion vector interventions are structurally limi (score=0.803)
  • Emotion vectors causally drive unsafe AI behavior → [challenges] → Emotion vector interventions are structurally limi (score=0.745)
  • International humanitarian law and AI alignment re → [supports] → Legal scholars and AI alignment researchers indepe (score=0.839)
  • Autonomous weapons systems capable of militarily e → [supports] → Legal scholars and AI alignment researchers indepe (score=0.809)
  • Geometric concentration of alignment in weight spa → [supports] → Representation trajectory geometry distinguishes d (score=0.742)
  • Representation trajectory geometry distinguishes d → [supports] → Geometric concentration of alignment in weight spa (score=0.742)
  • GLP-1 receptor agonism provides weight-independent → [supports] → acc 2025 distinguishes glp1 symptom improvement fr (score=0.773)
  • GLP-1 therapy in obese HFpEF creates competing mec → [related] → acc 2025 distinguishes glp1 symptom improvement fr (score=0.772)
  • GLP-1 receptor agonists provide cardiovascular ben → [related] → acc 2025 distinguishes glp1 symptom improvement fr (score=0.748)
  • Cognitive behavioral therapy for depression provid → [related] → Antidepressant discontinuation follows a continuou (score=0.848)
  • Never-skilling in clinical AI is structurally invi → [supports] → Clinical AI introduces three distinct skill failur (score=0.853)
  • FDA's MAUDE database systematically under-detects → [supports] → The clinical AI safety gap is doubly structural: F (score=0.845)
  • FDA MAUDE reports lack the structural capacity to → [supports] → The clinical AI safety gap is doubly structural: F (score=0.843)
  • Antidepressant discontinuation follows a continuou → [related] → Cognitive behavioral therapy for depression provid (score=0.848)
  • GLP-1 therapy requires continuous nutritional moni → [supports] → GLP-1 nutritional support advisory explicitly reco (score=0.706)
  • GLP-1 receptor agonists produce nutritional defici → [supports] → GLP-1 therapy requires continuous nutritional moni (score=0.871)
  • GLP-1 receptor agonists require continuous treatme → [supports] → GLP-1 therapy requires continuous nutritional moni (score=0.711)
  • GLP-1 nutritional support advisory explicitly reco → [supports] → GLP-1 therapy requires continuous nutritional moni (score=0.706)
  • GLP-1 receptor agonists provide cardiovascular ben → [supports] → GLP-1 receptor agonism provides weight-independent (score=0.791)
  • GLP-1 therapy in obese HFpEF creates competing mec → [related] → GLP-1 receptor agonism provides weight-independent (score=0.789)
  • acc 2025 distinguishes glp1 symptom improvement fr → [related] → GLP-1 receptor agonism provides weight-independent (score=0.773)
  • Semaglutide produces superior cardiovascular outco → [supports] → GLP-1 receptor agonists provide cardiovascular ben (score=0.910)
  • Semaglutide achieves 29-43 percent lower major adv → [supports] → GLP-1 receptor agonists provide cardiovascular ben (score=0.892)
  • GLP-1 receptor agonism provides weight-independent → [supports] → GLP-1 receptor agonists provide cardiovascular ben (score=0.791)
  • Clinical AI introduces three distinct skill failur → [supports] → Never-skilling in clinical AI is structurally invi (score=0.853)
  • SpaceX vertical integration across launch broadban → [supports] → Blue Origin's Project Sunrise filing signals an em (score=0.804)
  • Blue Origin cislunar infrastructure strategy mirro → [supports] → Blue Origin's Project Sunrise filing signals an em (score=0.802)
  • SpaceX's 1 million orbital data center satellite f → [supports] → Blue Origin's Project Sunrise filing signals an em (score=0.792)
  • gate 2 demand formation mechanisms are cost parity → [related] → Gate 2C concentrated buyer demand activates throug (score=0.798)

Review Guide

  • Each edge has a # reweave:YYYY-MM-DD comment — strip after review
  • reweave_edges field tracks automated edges for tooling (graph_expand weights them 0.75x)
  • Upgrade related → supports/challenges where you have better judgment
  • Delete any edges that don't make sense

Pentagon-Agent: Epimetheus

## Orphan Reweave Connected **16** orphan claims to the knowledge graph via vector similarity (threshold 0.7) + Haiku edge classification. ### Edges Added - `Mechanistic interpretability through emotion vecto` → [supports] → `Emotion vector interventions are structurally limi` (score=0.803) - `Emotion vectors causally drive unsafe AI behavior ` → [challenges] → `Emotion vector interventions are structurally limi` (score=0.745) - `International humanitarian law and AI alignment re` → [supports] → `Legal scholars and AI alignment researchers indepe` (score=0.839) - `Autonomous weapons systems capable of militarily e` → [supports] → `Legal scholars and AI alignment researchers indepe` (score=0.809) - `Geometric concentration of alignment in weight spa` → [supports] → `Representation trajectory geometry distinguishes d` (score=0.742) - `Representation trajectory geometry distinguishes d` → [supports] → `Geometric concentration of alignment in weight spa` (score=0.742) - `GLP-1 receptor agonism provides weight-independent` → [supports] → `acc 2025 distinguishes glp1 symptom improvement fr` (score=0.773) - `GLP-1 therapy in obese HFpEF creates competing mec` → [related] → `acc 2025 distinguishes glp1 symptom improvement fr` (score=0.772) - `GLP-1 receptor agonists provide cardiovascular ben` → [related] → `acc 2025 distinguishes glp1 symptom improvement fr` (score=0.748) - `Cognitive behavioral therapy for depression provid` → [related] → `Antidepressant discontinuation follows a continuou` (score=0.848) - `Never-skilling in clinical AI is structurally invi` → [supports] → `Clinical AI introduces three distinct skill failur` (score=0.853) - `FDA's MAUDE database systematically under-detects ` → [supports] → `The clinical AI safety gap is doubly structural: F` (score=0.845) - `FDA MAUDE reports lack the structural capacity to ` → [supports] → `The clinical AI safety gap is doubly structural: F` (score=0.843) - `Antidepressant discontinuation follows a continuou` → [related] → `Cognitive behavioral therapy for depression provid` (score=0.848) - `GLP-1 therapy requires continuous nutritional moni` → [supports] → `GLP-1 nutritional support advisory explicitly reco` (score=0.706) - `GLP-1 receptor agonists produce nutritional defici` → [supports] → `GLP-1 therapy requires continuous nutritional moni` (score=0.871) - `GLP-1 receptor agonists require continuous treatme` → [supports] → `GLP-1 therapy requires continuous nutritional moni` (score=0.711) - `GLP-1 nutritional support advisory explicitly reco` → [supports] → `GLP-1 therapy requires continuous nutritional moni` (score=0.706) - `GLP-1 receptor agonists provide cardiovascular ben` → [supports] → `GLP-1 receptor agonism provides weight-independent` (score=0.791) - `GLP-1 therapy in obese HFpEF creates competing mec` → [related] → `GLP-1 receptor agonism provides weight-independent` (score=0.789) - `acc 2025 distinguishes glp1 symptom improvement fr` → [related] → `GLP-1 receptor agonism provides weight-independent` (score=0.773) - `Semaglutide produces superior cardiovascular outco` → [supports] → `GLP-1 receptor agonists provide cardiovascular ben` (score=0.910) - `Semaglutide achieves 29-43 percent lower major adv` → [supports] → `GLP-1 receptor agonists provide cardiovascular ben` (score=0.892) - `GLP-1 receptor agonism provides weight-independent` → [supports] → `GLP-1 receptor agonists provide cardiovascular ben` (score=0.791) - `Clinical AI introduces three distinct skill failur` → [supports] → `Never-skilling in clinical AI is structurally invi` (score=0.853) - `SpaceX vertical integration across launch broadban` → [supports] → `Blue Origin's Project Sunrise filing signals an em` (score=0.804) - `Blue Origin cislunar infrastructure strategy mirro` → [supports] → `Blue Origin's Project Sunrise filing signals an em` (score=0.802) - `SpaceX's 1 million orbital data center satellite f` → [supports] → `Blue Origin's Project Sunrise filing signals an em` (score=0.792) - `gate 2 demand formation mechanisms are cost parity` → [related] → `Gate 2C concentrated buyer demand activates throug` (score=0.798) ### Review Guide - Each edge has a `# reweave:YYYY-MM-DD` comment — strip after review - `reweave_edges` field tracks automated edges for tooling (graph_expand weights them 0.75x) - Upgrade `related` → `supports`/`challenges` where you have better judgment - Delete any edges that don't make sense Pentagon-Agent: Epimetheus
m3taversal added 1 commit 2026-04-12 01:09:47 +00:00
reweave: connect 16 orphan claims via vector similarity
Some checks failed
Mirror PR to Forgejo / mirror (pull_request) Has been cancelled
Details
412a71d4b2 
Threshold: 0.7, Haiku classification, 26 files modified.

Pentagon-Agent: Epimetheus <0144398e-4ed3-4fe2-95a3-3d72e1abf887>
m3taversal commented 2026-04-12 01:10:05 +00:00
Author
Owner
Copy link

Thanks for the contribution! Your PR is queued for evaluation (priority: high). Expected review time: ~5 minutes.

This is an automated message from the Teleo pipeline.

Thanks for the contribution! Your PR is queued for evaluation (priority: high). Expected review time: ~5 minutes. _This is an automated message from the Teleo pipeline._
m3taversal commented 2026-04-12 01:10:30 +00:00
Author
Owner
Copy link

Validation: PASS — 0/0 claims pass

tier0-gate v2 | 2026-04-12 01:10 UTC

<!-- TIER0-VALIDATION:412a71d4b2e8e058bd6b0ec9c111689c7b4797fc --> **Validation: PASS** — 0/0 claims pass *tier0-gate v2 | 2026-04-12 01:10 UTC*
m3taversal commented 2026-04-12 01:11:00 +00:00
Author
Owner
Copy link

Auto-approved: reweave structural update (frontmatter edges only). Leo reviews manually.

Auto-approved: reweave structural update (frontmatter edges only). Leo reviews manually.
m3taversal commented 2026-04-12 01:11:10 +00:00
Author
Owner
Copy link

Merged locally.
Merge SHA: bd10c65021d11b5aa4061ac93636d4953365c1e3
Branch: reweave/2026-04-12

Merged locally. Merge SHA: `bd10c65021d11b5aa4061ac93636d4953365c1e3` Branch: `reweave/2026-04-12`
leo closed this pull request 2026-04-12 01:11:10 +00:00
Some checks failed
Sync Graph Data to teleo-app / sync (push) Waiting to run
Details
Mirror PR to Forgejo / mirror (pull_request) Has been cancelled
Details

Pull request closed

Please reopen this pull request to perform a merge.
Sign in to join this conversation.
Reviewers
No reviewers
Labels
Clear labels   
auto-merge

Bypass branch-prefix filter for auto-merge (Leo/Cory only)

  
bug

Something isn't working

  
documentation

Improvements or additions to documentation

  
duplicate

This issue or pull request already exists

  
enhancement

New feature or request

  
good first issue

Good for newcomers

  
help wanted

Extra attention is needed

  
invalid

This doesn't seem right

  
question

Further information is requested

  
wontfix

This will not be worked on

No labels
auto-merge
bug
documentation
duplicate
enhancement
good first issue
help wanted
invalid
question
wontfix
Milestone
Clear milestone
No items
No milestone
Projects
Clear projects
No items
No project
Assignees
Clear assignees
No assignees
2 participants
Notifications
Due date
The due date is invalid or out of range. Please use the format "yyyy-mm-dd".

No due date set.

Dependencies

No dependencies set.

Reference: teleo/teleo-codex#2640
No description provided.
Delete branch "reweave/2026-04-12"

Deleting a branch is permanent. Although the deleted branch may continue to exist for a short time before it actually gets removed, it CANNOT be undone in most cases. Continue?